REGENERX BIOPHARMACEUTICALS, INC. Shareholders' Equity
REGENERX BIOPHARMACEUTICALS, INC. had Shareholders' Equity of -$3.74 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-05-15
- 2023-03-31: Stockholders' Equity Attributable to Parent -$3.74M.
- 2022-12-31: Stockholders' Equity Attributable to Parent -$3.45M.
- 2022-09-30: Stockholders' Equity Attributable to Parent -$3.14M.
- 2022-06-30: Stockholders' Equity Attributable to Parent -$2.86M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-03-31 | -$3.74M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$3.45M 10-Q · filed 2023-05-15 | |
| 2022-09-30 | -$3.14M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$2.86M 10-Q · filed 2022-11-14 | |
| 2022-03-31 | -$2.57M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | -$2.23M 10-Q · filed 2023-05-15 | |
| 2021-09-30 | -$1.87M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$1.55M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$3.12M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$2.82M 10-K · filed 2023-04-11 | |
| 2020-09-30 | -$2.98M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$2.72M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$2.44M 10-Q · filed 2021-11-15 | -$2.44M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$2.34M 10-K · filed 2022-03-30 | |
| 2019-09-30 | -$2.04M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$1.76M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | -$1.96M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | -$2.21M 10-K · filed 2021-03-02 | |
| 2018-09-30 | -$2.00M 10-Q · filed 2019-11-14 | -$2.00M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$2.26M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | -$1.95M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | -$4.12M 10-K · filed 2020-03-20 | |
| 2017-09-30 | -$6.03M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$5.71M 10-Q · filed 2017-08-21 | |
| 2017-03-31 | -$5.89M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$6.07M 10-K · filed 2019-03-29 | |
| 2016-09-30 | -$6.54M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$7.47M 10-Q · filed 2016-08-22 | |
| 2016-03-31 | -$9.95M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$6.74M 10-K · filed 2018-03-29 | |
| 2015-09-30 | -$6.13M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$5.05M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$3.40M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$1.71M 10-K · filed 2017-03-29 | |
| 2014-09-30 | -$1.21M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$2.35M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$2.16M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$1.62M 10-K · filed 2016-04-11 | |
| 2013-09-30 | -$1.62M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | -$1.55M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$1.34M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$1.02M 10-K · filed 2015-03-31 | |
| 2012-09-30 | -$969.48K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$909.72K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$798.91K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$427.06K 10-K · filed 2014-04-04 | |
| 2011-09-30 | $186.08K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.00M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $3.61M 10-K · filed 2013-04-16 | |
| 2009-12-31 | $3.70M 10-K · filed 2012-04-04 |